SARS-CoV-2 Neutralizing Antibodies 2.0

SARS-CoV-2 Neutralizing Antibodies 2.0

As the SARS-CoV-2 mutates, especially into those variants causing immune escape, COVID-19 continues to wreak havoc [...]

Saved in:

Bibliographic Details
Main Author:	Youchun Wang
Format:	Article
Language:	English
Published:	MDPI AG 2024-11-01
Series:	Viruses
Subjects:	n/a
Online Access:	https://www.mdpi.com/1999-4915/16/11/1791
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SARS-CoV-2-Neutralizing Antibodies
by: Yawen Liu, et al.
Published: (2024-11-01)

New Trends in SARS-CoV-2 Variants and Vaccines
by: Seik-Soon Khor
Published: (2025-03-01)

Presence of neutralizing SARS‐CoV‐2 antibodies in asymptomatic population of N'Djamena, Chad
by: Andrillene Laure Deutou Wondeu, et al.
Published: (2024-01-01)

Cross-neutralization of Influenza A by SARS-CoV-2 specific neutralizing antibodies and polyclonal plasma: Is pre-exposure to SARS-CoV-2 protective against Influenza A?
by: Mohammad Mamun Alam, et al.
Published: (2024-12-01)

SARS-CoV-2 spike S2-specific neutralizing antibodies
by: Chia-Jung Li, et al.
Published: (2023-12-01)

Evaluation of the MAScIR SARS-CoV-2 M Kit 2.0 on the SARS-CoV-2 Infection
by: Amal Zouaki, et al.
Published: (2023-01-01)

Animal Venoms and Their Components: Molecular Mechanisms of Action V 2.0
by: Yuri Utkin
Published: (2024-10-01)

Optimizing the breadth of SARS-CoV-2-neutralizing antibodies in vivo and in silico
by: Daisuke Kuroda, et al.
Published: (2025-12-01)

Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission
by: Young-Il Kim, et al.
Published: (2021-01-01)

Dairy Fermentation 2.0
by: Thomas Bintsis
Published: (2024-09-01)

Optimizing a human monoclonal antibody for better neutralization of SARS-CoV-2
by: Qian Wang, et al.
Published: (2025-07-01)

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
by: Jianhui Nie, et al.
Published: (2020-01-01)

Models for Oral Biology Research 2.0
by: Fernando Capela e Silva, et al.
Published: (2024-12-01)

Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19
by: Pengcheng Liu, et al.
Published: (2020-01-01)

Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern
by: Lei Yue, et al.
Published: (2021-01-01)

Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodies
by: Andrew Dippel, et al.
Published: (2023-12-01)

Neutralizing antibodies to SARS-CoV-2 variants of concern: a pediatric surveillance study
by: Douglas D. Fraser, et al.
Published: (2025-04-01)

Special Issue “Exercise and Neurodegenerative Disease 2.0”
by: Grazia Maugeri, et al.
Published: (2024-12-01)

Marine Bioactive Peptides—Structure, Function, and Application 2.0
by: Bin Wang, et al.
Published: (2025-04-01)

Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment.
by: Elizabeth S Munroe, et al.
Published: (2025-01-01)

Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment
by: Elizabeth S. Munroe, et al.
Published: (2025-01-01)

A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge
by: Xiangchuan He, et al.
Published: (2021-01-01)

Impaired potency of neutralizing antibodies against cell–cell fusion mediated by SARS-CoV-2
by: Qian Wang, et al.
Published: (2023-12-01)

Structural insights into broadly neutralizing antibodies elicited by hybrid immunity against SARS-CoV-2
by: Mengxiao Luo, et al.
Published: (2023-12-01)

Correction: Nocini et al. Improving Nasal Protection for Preventing SARS-CoV-2 Infection. <i>Biomedicines</i> 2022, <i>10</i>, 2966
by: Riccardo Nocini, et al.
Published: (2025-07-01)

Recurrent waning of anti-SARS-CoV-2 neutralizing antibodies despite multiple antigen encounters
by: Edwards Pradenas, et al.
Published: (2025-07-01)

Systemic inflammation is associated with worse outcomes from SARS-CoV-2 infection but not neutralizing antibody
by: Christopher W. Farnsworth, et al.
Published: (2025-04-01)

Equine Hyperimmune Serum against the Inactivated SARS-CoV-2 Has Antibodies Neutralizing Titers
by: Neida Lucia Conrad, et al.
Published: (2025-07-01)

Neutralizing antibody responses to SARS-CoV-2 variants after COVID-19 vaccination and boosters
by: Kabita Adhikari, et al.
Published: (2025-06-01)

Neutralizing antibodies for SARS-CoV-2 in stray animals from Rio de Janeiro, Brazil.
by: Helver Gonçalves Dias, et al.
Published: (2021-01-01)

Adjuvant-driven antibody response to use cows as biofactories of anti-SARS-CoV-2 neutralizing antibodies in colostrum
by: E.B. Gaspar, et al.
Published: (2025-04-01)

The persistence of SARS-CoV-2 neutralizing antibodies after COVID-19: A one-year observation. Is a SARS-CoV-2 vaccination booster dose necessary?
by: Adam Tworek, et al.
Published: (2023-03-01)

Brain Injury and Neurodegeneration: Molecular, Functional, and Translational Approach 2.0
by: Pankaj Ahluwalia, et al.
Published: (2024-11-01)

Potent and broadly neutralizing antibodies against sarbecoviruses elicited by single ancestral SARS-CoV-2 infection
by: Lei Yu, et al.
Published: (2025-03-01)

The Intra-Host Evolution of SARS-CoV-2 After Neutralizing Antibody Therapy, Revealed by Nanopore Sequencing
by: Hong-Xiang Zeng, et al.
Published: (2024-01-01)

Seroprevalence and influencing factors of low-level neutralizing antibodies against SARS-CoV-2 in community residents
by: YUAN Shiying, et al.
Published: (2025-05-01)

Lack of cross-neutralization by SARS patient sera towards SARS-CoV-2
by: Danielle E. Anderson, et al.
Published: (2020-01-01)

Neutrophils, Fast and Strong 2.0: Heterogeneity of Neutrophil Parameters in Health and in Disease
by: Galina F. Sud’ina
Published: (2025-02-01)

Structural insight into broadening SARS-CoV-2 neutralization by an antibody cocktail harbouring both NTD and RBD potent antibodies
by: Wenling Jiang, et al.
Published: (2024-12-01)

Total antibodies and neutralizing ability of convalescent sera against three different strains of SARS-CoV-2
by: Natalia V. Palyanova, et al.
Published: (2025-03-01)